Cartilage and Bone Serum Biomarkers as Novel Tools for Monitoring Knee Osteochondritis Dissecans Treated with Osteochondral Scaffold

Figure 2

Serum biomarkers evaluation in OCD during the follow-up. Biomarkers of cartilage degradation (CTXII; C2C) and synthesis (CPII) and of bone degradation (TRAP5b) and synthesis (OC) at three different time points (T0= basal, T1= 3 months, and T2= 1 year) are represented as mean ± SD. CTXII, C2C, CPII, and OC were expressed as ng/ml while TRAP5b as U/ml. Significant results are indicated.

(a)

(b)

(c)

(d)

(e)